Skip to main content
Mauna Kea Technologies logo

Mauna Kea Technologies — Investor Relations & Filings

Ticker · MKEA ISIN · FR0010609263 LEI · 5493007KMDG4MFIGJJ63 PA Manufacturing
Open in API
Filings indexed 774 across all filing types
Latest filing 2016-02-25 Regulatory Filings
Country FR France
Listing PA MKEA

About Mauna Kea Technologies

https://www.maunakeatech.com/en/

Mauna Kea Technologies is a medical device company that develops and markets the Cellvizio® platform, a real-time in vivo cellular imaging system. The platform utilizes Confocal Laser Endomicroscopy (CLE) technology, enabling physicians to visualize tissue at the cellular level during medical procedures. This "optical biopsy" is performed using flexible, miniature fiber-optic probes (Confocal Miniprobes™) that are compatible with standard endoscopes. The core function of Cellvizio® is to provide immediate microscopic visualization, which aids in accelerating diagnosis, informing treatment strategies, and improving the precision of therapeutic interventions. Key applications include gastroenterology (for conditions such as Barrett's esophagus and pancreatic cysts), interventional pulmonology (lung cancer diagnostics), urologic oncology, and neurosurgery. The technology supports enhanced surgical procedures, including real-time margin assessment, and is being integrated with robotic surgery and AI-assisted imaging systems.

Recent filings

Filing Released Lang Actions
MAUNA KEA TECHNOLOGIES TERMINE LE RECRUTEMENT DES 200 PATIENTS DE L’ÉTUDE CONTACT II SUR LA CARACTÉRISATION DES KYSTES DU PANCRÉAS AVEC L'ENDOMICROSCOPIE CONFOCALE PAR AIGUILLE
Regulatory Filings Classification · 99% confidence The document is a press release dated February 25, 2016, announcing that Mauna Kea Technologies has completed patient recruitment for its CONTACT II study and noting the publication of related clinical reviews. It contains quotes from management and doctors, and concludes with contact information and a note stating, 'Ceci est un communiqué d'informations réglementaires diffusé par PR Newswire' (This is a regulatory information release distributed by PR Newswire). This structure strongly indicates a general regulatory announcement or press release that doesn't fit the specific financial report categories (like 10-K, IR, ER). Since it is a general regulatory announcement and not a specific financial report, the most appropriate fallback category is Regulatory Filings (RNS). The document length (4801 chars) is substantial enough to be the announcement itself, not just a brief notice of publication (RPA).
2016-02-25 French
MAUNA KEA TECHNOLOGIES FAIT SON ENTRÉE SUR LE MARCHÉ OTCQX AUX ÉTATS-UNIS
Regulatory Filings Classification · 100% confidence The document is a press release dated February 17, 2016, announcing that Mauna Kea Technologies' American Depositary Receipts (ADRs) have been listed on the OTCQX Best Market in the United States. This is a corporate action related to market listing and capital structure visibility, but it is not a formal regulatory filing like a 10-K, an earnings release (ER), or a dividend notice (DIV). It is an announcement about market access and corporate structure visibility. Since it is a specific announcement regarding market listing and investor access rather than a general regulatory filing fallback (RNS), and it doesn't fit the definitions for Capital/Financing Update (CAP) which usually involves raising funds or debt, the most appropriate category is Regulatory Filings (RNS) as a general corporate announcement, or potentially Capital/Financing Update (CAP) due to the listing affecting capital access. However, given the nature of the announcement—a listing on a secondary market (OTCQX) to increase visibility—it is best classified as a general regulatory announcement or a filing that doesn't fit elsewhere. Given the options, RNS (Regulatory Filings) serves as the best general category for significant, non-standard corporate news releases that aren't explicitly covered by other codes like ER, 10-K, or DIV. The document length (3936 chars) is substantial enough that it is the announcement itself, not just a notice of publication (RPA).
2016-02-17 French
CORRECTION - Mauna Kea Technologies: Mauna Kea Technologies Begins Trading on OTCQX in the U.S.
Regulatory Filings Classification · 99% confidence The document is a press release correcting a previous announcement regarding Mauna Kea Technologies commencing trading of its American Depositary Receipts (ADRs) on the OTCQX market in the U.S. This announcement details a change in the company's listing/trading status and ticker symbol, which relates to its capital structure and market presence. It is not a full annual report (10-K), an earnings release (ER), or a formal regulatory filing like a DVA or DIRs. Since it announces a change related to the company's shares/listing on an exchange, it most closely aligns with Capital/Financing Update (CAP) or potentially a general Regulatory Filing (RNS). Given the specific nature of announcing a new US trading venue (OTCQX) and ticker, it fits best under Capital/Financing Update (CAP) as it directly impacts how capital is traded, although it is also a general announcement. However, since it is a press release announcing a market/share event, and 'CAP' covers financing activities, this is the most appropriate specific category over the general 'RNS'. The document length is short (3863 chars), but it contains the full substance of the announcement, not just a notice that a report is attached, thus avoiding the RPA classification.
2016-02-17 English
Mauna Kea Technologies Begins Trading on OTCQX in the U.S.
Delisting Announcement Classification · 99% confidence The document announces that Mauna Kea Technologies has commenced trading of its sponsored Level 1 American Depositary Receipts (ADRs) on the OTCQX® International market in the U.S. This is a corporate action related to the company's stock listing and capital structure visibility in a new market. It is not a standard periodic financial report (10-K, IR), an earnings release (ER), or a dividend announcement (DIV). It specifically relates to changes in how the company's shares are traded and structured for U.S. investors, which aligns best with 'Capital/Financing Update' (CAP) as it involves the structure of its securities for a new market, or potentially 'Regulatory Filings' (RNS) as a general announcement. Given the focus on the listing mechanism (ADRs on OTCQX), it is most closely related to capital structure changes or market access, making CAP a strong candidate. However, since it is a press release announcing a listing change rather than a formal filing about raising capital or a stock split, and it doesn't fit other specific categories, it could also be considered a general regulatory announcement. Comparing CAP (Financing Activities) vs. RNS (General Regulatory Announcement): The announcement is about market access and security structure (ADRs), which is a form of financing/capital structure activity. I will classify it as CAP because it directly impacts the trading mechanism and structure of the security in a new jurisdiction, which is a financing-related event.
2016-02-17 English
Mauna Kea Technologies Announces Expanded Strategic Multiyear Partnership With Fujifilm China
Regulatory Filings Classification · 100% confidence The document is a press release announcing an expanded strategic partnership between Mauna Kea Technologies and Fujifilm China regarding the commercialization of the Cellvizio platform. It details business developments, strategic alignment, and market expansion. This type of announcement, which is not a formal regulatory filing like a 10-K, an earnings release (ER), or a specific financial report (like IR or AR), fits best under the general category for regulatory announcements or press releases that convey material, non-financial business updates. Since it is a general business announcement and not explicitly covered by the other specific codes (like MANG, CAP, or TAR), the most appropriate fallback category is Regulatory Filings (RNS), which often serves as a catch-all for material press releases not fitting elsewhere.
2016-02-01 English
Mauna Kea Technologies annonce l'extension de son partenariat stratégique avec Fujifilm China
Regulatory Filings Classification · 95% confidence The document is a press release dated February 1, 2016, announcing the extension of a strategic partnership between Mauna Kea Technologies and Fujifilm China regarding the commercialization of the Cellvizio platform in China. It details business developments, strategic alignment, and market expansion. This type of announcement, which is a general corporate update that doesn't fit neatly into specific financial reporting categories (like 10-K, ER, or DIV), is best classified as a general Regulatory Filing or Announcement. Since it is a press release about a business development and not a formal regulatory filing like a 10-K or a specific financial event, the most appropriate general category is Regulatory Filings (RNS), as it serves as a catch-all for official company announcements not covered elsewhere. The document length (2757 chars) is short, but it is a complete announcement, not just a notice that a report is attached, so RPA is less suitable than RNS for a general business update.
2016-02-01 French

Browse filings by year

15 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.